Industries > Pharma > Clinical Trial Supply and Logistics: World Market Outlook 2013-2023
Clinical Trial Supply and Logistics: World Market Outlook 2013-2023
Organisation of clinical trials – new study announcing that industry’s sales prospects
What’s the outlook for the supplying and arrangement of medical testing? Visiongain’s new report gives you revenue predictions, helping you stay ahead. There you see financial prospects. You also explore R&D trends, technologies, clients’ needs, and opportunities.
That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. See what’s happening, then, for those pharmaceutical contracting services – outsourcing and off-shoring – finding how you can gain.
Read on to explore that industry and discover what its future market could be worth.
Forecasts from 2013-2023 and other information to help you stay ahead in knowledge
Besides sales forecasting there to 2023, our new work shows historical data, growth rates, and market shares. There you find original analysis. See research and development (R&D) needs too. You also get 51 tables, 59 charts, and two interviews with companies.
Our study shows you what the future holds for pharma contract research organisations (CROs) and contract manufacturers (CMOs) supporting clinical trials.
You also see outlooks for related companies, including specialists in logistical support. See, too, implications for drug developers and clinical trial sponsors.
Gains through understanding those developmental services – advantages for your work
Why miss information you need? Why struggle to find data? Instead let our analysis guide you through that outsourcing industry’s present and future.
That knowledge could bring you quicker, easier decisions, and results. Also you gain understanding to benefit your authority on clinical testing of drugs.
So use our predictions to help expand your business and give you more influence. You get the forecasting leaders need. Avoid falling behind there – find where the money lies.
The following sections show what you get, then, in our new investigation.
Revenues for the world clinical trial supply and logistics market and its submarkets
What are the secrets of that industry’s progress? Along with prediction of the overall world market for that service provision, our work shows you individual revenue forecasting of three submarkets to 2023, at world level, for clinical trials:
• Manufacturing – also with forecasts for packaging and for other production
• Logistics and distribution – also with forecasts for cold chain logistics and for other services
• Supply chain management.
That report gives you feel for what stimulates and restrains that industry and market. There you identify potential for those technologies and services. See, then, how you can benefit.
You also find geographical revenue predictions.
National markets – what outlooks for service demand and provision?
Our analyses show you individual revenue forecasts to 2023 for 11 national markets:
• United States (US)
• EU leaders – Germany, France, the UK, Italy, and Spain (EU5)
• BRIC countries – Brazil, Russia, India, and China.
For pharma service providers and clients, many opportunities exist in developed and developing countries. Progress worldwide will influence that market for outsourced services. See there how you and your organisation can benefit.
You find prospects. Our work explains, also exploring issues.
Developments, challenges, and opportunities affecting CROs, CMOs and other companies
The report explains forces affecting that industry and market from 2013, including these:
• Globalisation – access to new markets and patients
• Regulatory standards for clinical trial supply, inc. good manufacturing practice (GMP) and good distribution practice (GDP)
• Import regulations
• Supply chain security and other technology for developing and testing medicines
• Biological drugs (biologics) and other complex pharmaceuticals.
And also for these:
• Forecasting and modelling to maintain supply
• IT systems for clinical trial planning: IVRS and IWRS
• Participation in trials at home
• Adaptive clinical trials
• Management of multiple supplier networks.
There you explore political, economic, social, and technological questions, assessing outlooks for business. You also gain regulatory insights.
See there what the future holds.
Companies leading that industry and its overall 2017 value
What’s possible for that industry? Our report predicts the world market for that clinical trial support will reach $14.3bn in 2017, expanding to 2023.
That work also shows you what technologies and organisations hold greatest potential. In particular, you explore activities of these companies:
• Catalent Pharma Solutions
• Almac Group
• Parexel International
• Fisher Clinical Services (FCS).
Our study also covers these firms, among others:
• World Courier
• TNT Express
You find 115 organisations covered. You also read interviews with two leaders in the industry. Discover, then, what participants do, say, and think, helping you stay ahead.
Analysis found nowhere else – discover the future of that pharma outsourcing
Through knowledge such as this, our new report helps you:
• Revenues to 2023 at world level for supporting clinical trials, with forecasts for 3 submarkets – assess prospects for investments, marketing, and revenues
• Forecasts to 2023 for 11 national markets in the Americas, Europe, and Asia -investigate developed and developing countries for potential sales
• Outlooks for established and rising service providers – assess results, portfolios, capabilities, clients, and prospects.
Clinical Trial Supply and Logistics: World Market Outlook 2013-2023 provides independent analysis. There you get competitive intelligence found only in our work, finding where money lies. Explore progress and possibilities.
See there how you could benefit your research, analysis, and decisions. Also find how you can save time and get recognition for insight. Try that study.
Ordering now lets you discover predictions to 2023, finding information you need
Our new report shows you data, trends, opportunities, and revenue predictions to 2023 for providers of clinical trial support. Avoid missing out, then – please order now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
To view free sample pages of this report please click here